Besides, we also explored that loss of Setd2 in ISCs exacerbates DSS-induced colitis in mice and targeted delivery of Grem1 by AT-MSCs shows higher efficacy in Setd2-deficient colitis. The gene discussed is GREM1; the disease is colitis.